MLX plays a key role in lipid and glucose metabolism in humans: evidence from in vitro and in vivo studies
<p><strong>Background and aim</strong></p> Enhanced hepatic de novo lipogenesis (DNL) has been proposed as an underlying mechanism for the development of NAFLD and insulin resistance. Max-like protein factor X (MLX) acts as a heterodimer binding partner for glucose sensing t...
Автори: | Nagarajan, SR, Livingstone, EJ, Monfeuga, T, Lewis, LC, Ali, SHL, Chandran, A, Neville, MJ, Dearlove, DJ, Chen, L, Maroteau, C, Ruby, MA, Hodson, L |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Elsevier
2023
|
Схожі ресурси
Схожі ресурси
-
Hepatic fatty acid and glucose handling in metabolic disease: potential impact on cardiovascular disease risk
за авторством: Westcott, F, та інші
Опубліковано: (2023) -
Application of MLX90251 in Intelligent Motor Protectio
за авторством: LI Run-chun, та інші
Опубліковано: (2010-05-01) -
The glucose-sensing transcription factor MLX balances metabolism and stress to suppress apoptosis and maintain spermatogenesis.
за авторством: Patrick A Carroll, та інші
Опубліковано: (2021-10-01) -
DEVELOPMENT OF AN IOT DEVICE USING MLX90640 SENSORS FOR TEMPERATURE ACQUISITION
за авторством: Dan Noje, та інші
Опубліковано: (2022-12-01) -
Low-cost teslameter based on hall effect sensor MLX90242
за авторством: Jovanović Uglješa, та інші
Опубліковано: (2018-01-01)